Inventors:
Michael J. Conder - Harrisonburg VA
Steven J. Cianciosi - Harrisonburg VA
William H. Cover - Lansdale PA
Rebecca L. Dabora - Andover MA
Eric T. Pisk - Harrisonburg VA
Robert W. Stieber - Harrisonburg VA
Bogdan Tehlewitz - McGaheysville VA
Gregory L. Tewalt - Shenandoah VA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C12P 1700
C12P 1706
C12N 914
C07D30930
Abstract:
Biosynthetic production of 7-[1',2',6',-7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'( S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid, "triol acid", is accomplished by enzymatic hydrolysis of lovastatin acid or a salt thereof, by treating it with Clonostachys compactiuscula ATCC 38009 or ATCC 74178, or mutants thereof, or a cell-free extract derived therefrom, or a hydrolase derived therefrom. The triol acid and its lactone form are both inhibitors of HMG-CoA reductase and thus useful as anti-hypercholesterolemic agents, and may also serve as intermediates for preparation of other HMG-CoA reductase inhibitors. Also, in the synthesis of simvastatin by direct methylation of lovastatin, selective hydrolysis of residual lovastatin salt by treatment with Clonostachys compactiuscula ATCC 38009 or ATCC 74178 or mutants thereof or a cell-free extract derived therefrom, or a hydrolase derived therefrom yields the "triol" salt which can be easily separated from simvastatin.